BPC-157 vs Pentosan Polysulfate

Overview

BPC-157 and Pentosan Polysulfate are both bone & joint peptides, but they differ in mechanism, dosing, and regulatory status.

This page compares BPC-157 and Pentosan Polysulfate across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

Key differences

Primary use. BPC-157 is categorised under Bone & Joint, while Pentosan Polysulfate falls under Bone & Joint. Because they target a similar goal, they are common alternatives to weigh against each other.

Regulatory status. BPC-157: not FDA-approved; compounding permitted with a prescription as of April 2026. Pentosan Polysulfate: not FDA-approved; treated as a research compound.

Dosing. BPC-157 is typically dosed at 250-500 mcg (daily). Pentosan Polysulfate is typically dosed at 100 mg (three times weekly).

Can you stack them?

Some protocols combine peptides, but stacking BPC-157 and Pentosan Polysulfate has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between BPC-157 and Pentosan Polysulfate?

BPC-157 and Pentosan Polysulfate are both bone & joint peptides, but they differ in mechanism, dosing, and regulatory status. BPC-157 is not FDA-approved; compounding permitted with a prescription (as of April 2026), whereas Pentosan Polysulfate is not FDA-approved; generally classified as a research compound.

What is BPC-157 used for?

Bone and cartilage healing.

What is Pentosan Polysulfate used for?

Cartilage and joint protection.

Can you take BPC-157 and Pentosan Polysulfate together?

Some users combine peptides within a single protocol, but stacking BPC-157 and Pentosan Polysulfate has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.

Is BPC-157 or Pentosan Polysulfate FDA-approved?

BPC-157 is not FDA-approved; compounding permitted with a prescription (as of April 2026). Pentosan Polysulfate is not FDA-approved; generally classified as a research compound.